Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-Administered Nasal Influenza Vaccine: Immunogenicity and Feasibility of Group Administration

NCT01933048 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT01933048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01933048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-Administered Nasal Influenza Vaccine: Immunogenicity and Feasibility of Group Administration
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
October 31, 2013
Enrollment
1,077 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza